Bank CEOs meet with Trump to discuss Fannie Mae and Freddie Mac - Bloomberg
In a recent transaction, Allyson Guidroz, the Chief Accounting Officer of Amedisys Inc . (NASDAQ:AMED), sold 2,041 shares of the company’s common stock. The sale, executed on March 4, 2025, was conducted at an average price of $92.03 per share, generating a total of $187,833. The transaction comes as Amedisys, with a market capitalization of $3.54 billion, trades near its 52-week high of $98.95. Following this transaction, Guidroz holds 8,761 shares directly. Additionally, there is a separate indirect holding of 1.5 shares through a 401(k) plan. These transactions were detailed in a Form 4 filing with the Securities and Exchange Commission. According to InvestingPro analysis, Amedisys currently trades at a P/E ratio of 69.9, though the stock shows historically low price volatility. InvestingPro’s Fair Value model suggests the stock may be slightly undervalued, with additional insights available through their premium service.
In other recent news, Amedisys Inc. has experienced significant developments regarding its merger with UnitedHealth Group (NYSE:UNH). The merger agreement has been extended to December 31, 2025, amid scrutiny from the U.S. Department of Justice, which raised antitrust concerns. This extension includes an increased break fee, now set between $275 million and $325 million, if UnitedHealth fails to divest certain assets by May 1, 2025. Meanwhile, RBC Capital Markets continues to maintain an Outperform rating on Amedisys, reinforcing confidence in the merger’s alignment with UnitedHealth’s strategic goals. Additionally, Amedisys has terminated its agreement to sell certain home health centers to VCG Luna, influenced by legal challenges and antitrust concerns. At the company’s recent annual meeting, shareholders elected nine directors and ratified KPMG LLP as independent accountants. These developments are closely monitored by investors, given their potential impact on Amedisys’s business strategy and operations.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.